| 1 |
A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours.Cancers (Basel). 2019 Sep 6;11(9):1322. doi: 10.3390/cancers11091322.
|
| 2 |
CCDN1 rs603965 polymorphism may serve as a genetic biomarker of brain tumor: A meta-analysis of 5,769 subjects.Mol Genet Genomic Med. 2019 Jun;7(6):e00655. doi: 10.1002/mgg3.655. Epub 2019 Apr 10.
|
| 3 |
Computer-Aided Discovery of Small Molecule Inhibitors of Transcriptional Activity of TLX (NR2E1) Nuclear Receptor.Molecules. 2018 Nov 14;23(11):2967. doi: 10.3390/molecules23112967.
|
| 4 |
Balanced Steady-State Free Precession Sequence (CISS/FIESTA/3D Driven Equilibrium Radiofrequency Reset Pulse) Increases the Diagnostic Yield for Spinal Drop Metastases in Children with Brain Tumors.AJNR Am J Neuroradiol. 2018 Jul;39(7):1355-1361. doi: 10.3174/ajnr.A5645. Epub 2018 May 17.
|
| 5 |
Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors.Front Pharmacol. 2017 Feb 15;8:54. doi: 10.3389/fphar.2017.00054. eCollection 2017.
|
| 6 |
Hemoglobins, Hemorphins, and 11p15.5 Chromosomal Region in Cancer Biology and mmunity with Special Emphasis for Brain Tumors.J Neurol Surg A Cent Eur Neurosurg. 2016 May;77(3):247-57. doi: 10.1055/s-0035-1566120. Epub 2016 Mar 2.
|
| 7 |
Imaging of Integrin (v)(3) Expression in Lung Cancers and Brain Tumors Using Single-Photon Emission Computed Tomography with a Novel Radiotracer (99m)Tc-IDA-D-[c(RGDfK)](2).Cancer Biother Radiopharm. 2017 Oct;32(8):288-296. doi: 10.1089/cbr.2017.2233.
|
| 8 |
Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-B signaling improves the efficacy of immunotherapy in a brain cancer model.Neurotherapeutics. 2012 Oct;9(4):827-43. doi: 10.1007/s13311-012-0144-7.
|
| 9 |
LGR5 and Downstream Intracellular Signaling Proteins Play Critical Roles in the Cell Proliferation of Neuroblastoma, Meningioma and Pituitary Adenoma.Exp Neurobiol. 2019 Oct 31;28(5):628-641. doi: 10.5607/en.2019.28.5.628.
|
| 10 |
DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.Chin Med J (Engl). 2019 Jan 20;132(2):161-170. doi: 10.1097/CM9.0000000000000054.
|
| 11 |
Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.BMC Neurol. 2010 Aug 19;10:71. doi: 10.1186/1471-2377-10-71.
|
| 12 |
C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.Mol Oncol. 2018 Sep;12(9):1464-1479. doi: 10.1002/1878-0261.12349. Epub 2018 Aug 2.
|
| 13 |
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Emerging and Investigational Therapties for the Treatment of Adults With Metastatic Brain Tumors.Neurosurgery. 2019 Mar 1;84(3):E201-E203. doi: 10.1093/neuros/nyy547.
|
| 14 |
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1970-82. doi: 10.1158/1078-0432.CCR-05-2797.
|
| 15 |
Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells.FEBS Lett. 2008 Mar 5;582(5):799-804. doi: 10.1016/j.febslet.2008.01.061. Epub 2008 Feb 11.
|
| 16 |
Proteomics-based analysis of invasion-related proteins in malignant gliomas.Neuropathology. 2013 Jun;33(3):264-75. doi: 10.1111/j.1440-1789.2012.01361.x. Epub 2012 Nov 1.
|
| 17 |
Substituted (E)-2-(2-benzylidenehydrazinyl)-4-methylthiazole-5-carboxylates as dual inhibitors of 15-lipoxygenase & carbonic anhydrase II: synthesis, biochemical evaluation and docking studies.Biochem Biophys Res Commun. 2017 Jan 1;482(1):176-181. doi: 10.1016/j.bbrc.2016.11.028. Epub 2016 Nov 9.
|
| 18 |
Gene expression profiling of metastatic brain cancer.Oncol Rep. 2007 Aug;18(2):321-8.
|
| 19 |
CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors.Int J Cancer. 2002 Mar 20;98(3):352-6. doi: 10.1002/ijc.10207.
|
| 20 |
Casein kinase 2 regulates glioblastoma brain tumor-initiating cell growth through the -catenin pathway.Oncogene. 2015 Jul;34(28):3688-99. doi: 10.1038/onc.2014.299. Epub 2014 Sep 22.
|
| 21 |
Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma.Int J Pharm. 2013 Mar 10;445(1-2):79-87. doi: 10.1016/j.ijpharm.2013.01.057. Epub 2013 Feb 4.
|
| 22 |
Effect of Retro-Inverso Isomer of Bradykinin on Size-Dependent Penetration of Blood-Brain Tumor Barrier.Small. 2018 Feb;14(7). doi: 10.1002/smll.201702331. Epub 2018 Jan 2.
|
| 23 |
Targeting DNA-PKcs and telomerase in brain tumour cells.Mol Cancer. 2014 Oct 13;13:232. doi: 10.1186/1476-4598-13-232.
|
| 24 |
Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.Cancer Res. 1998 May 1;58(9):1798-803.
|
| 25 |
Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal.J Neurooncol. 2008 Feb;86(3):285-96. doi: 10.1007/s11060-007-9477-1. Epub 2007 Oct 11.
|
| 26 |
TMS motor mapping in brain tumor patients: more robust maps with an increased resting motor threshold.Acta Neurochir (Wien). 2019 May;161(5):995-1002. doi: 10.1007/s00701-019-03883-8. Epub 2019 Mar 29.
|
| 27 |
Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncol. 2008;47(6):1062-70.
|
| 28 |
Targeted induction of apoptosis in glioblastoma multiforme cells by an MRP3-specific TRAIL fusion protein in vitro.Tumour Biol. 2014 Feb;35(2):1157-68. doi: 10.1007/s13277-013-1155-7. Epub 2013 Nov 26.
|
| 29 |
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain Barrier.J Nucl Med. 2019 Apr;60(4):486-491. doi: 10.2967/jnumed.118.216432. Epub 2018 Sep 20.
|
| 30 |
ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.Clin Sci (Lond). 2019 Jan 11;133(1):83-99. doi: 10.1042/CS20180906. Print 2019 Jan 15.
|
| 31 |
Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers.Front Oncol. 2019 Feb 25;9:96. doi: 10.3389/fonc.2019.00096. eCollection 2019.
|
| 32 |
The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of patients with brain tumor.Arch Med Sci. 2017 Mar 1;13(2):346-352. doi: 10.5114/aoms.2017.65366. Epub 2017 Jan 23.
|
| 33 |
Comparison of occupational exposure assessment methods in a case-control study of lead, genetic susceptibility and risk of adult brain tumours.Occup Environ Med. 2011 Jan;68(1):4-9. doi: 10.1136/oem.2009.048132. Epub 2010 Aug 25.
|
| 34 |
Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?.Cancer Biol Ther. 2012 Dec;13(14):1376-83. doi: 10.4161/cbt.22255. Epub 2012 Sep 17.
|
| 35 |
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth.Dis Model Mech. 2017 Jan 1;10(1):15-28. doi: 10.1242/dmm.026500. Epub 2016 Nov 24.
|
| 36 |
Brain Tumor promotes axon growth across the midline through interactions with the microtubule stabilizing protein Apc2.PLoS Genet. 2018 Apr 4;14(4):e1007314. doi: 10.1371/journal.pgen.1007314. eCollection 2018 Apr.
|
| 37 |
Apurinic endonuclease-1 preserves neural genome integrity to maintain homeostasis and thermoregulation and prevent brain tumors.Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12285-E12294. doi: 10.1073/pnas.1809682115. Epub 2018 Dec 11.
|
| 38 |
AQP9 expression in glioblastoma multiforme tumors is limited to a small population of astrocytic cells and CD15(+)/CalB(+) leukocytes.PLoS One. 2013 Sep 25;8(9):e75764. doi: 10.1371/journal.pone.0075764. eCollection 2013.
|
| 39 |
Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies.Oncotarget. 2017 Jun 29;8(38):63506-63517. doi: 10.18632/oncotarget.18843. eCollection 2017 Sep 8.
|
| 40 |
Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.J Neurooncol. 2019 Jul;143(3):417-428. doi: 10.1007/s11060-019-03192-1. Epub 2019 May 21.
|
| 41 |
The expression of BST2 in human and experimental mouse brain tumors.Exp Mol Pathol. 2011 Aug;91(1):440-6. doi: 10.1016/j.yexmp.2011.04.012. Epub 2011 May 1.
|
| 42 |
Topiramate induces acute intracellular acidification in glioblastoma.J Neurooncol. 2016 Dec;130(3):465-472. doi: 10.1007/s11060-016-2258-y. Epub 2016 Sep 9.
|
| 43 |
Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor.Front Oncol. 2019 Apr 26;9:307. doi: 10.3389/fonc.2019.00307. eCollection 2019.
|
| 44 |
Voltage-gated calcium channels: Novel targets for cancer therapy.Oncol Lett. 2017 Aug;14(2):2059-2074. doi: 10.3892/ol.2017.6457. Epub 2017 Jun 22.
|
| 45 |
Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?.Neurosurgery. 1994 Sep;35(3):439-48; discussion 448-9. doi: 10.1227/00006123-199409000-00012.
|
| 46 |
A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors.Radiat Oncol. 2017 Feb 22;12(1):40. doi: 10.1186/s13014-017-0775-2.
|
| 47 |
Utilizing the Dog Genome in the Search for Novel Candidate Genes Involved in Glioma Development-Genome Wide Association Mapping followed by Targeted Massive Parallel Sequencing Identifies a Strongly Associated Locus.PLoS Genet. 2016 May 12;12(5):e1006000. doi: 10.1371/journal.pgen.1006000. eCollection 2016 May.
|
| 48 |
Influence of multiple delays in brain tumor and immune system interaction with T11 target structure as a potent stimulator.Math Biosci. 2018 Aug;302:116-130. doi: 10.1016/j.mbs.2018.06.001. Epub 2018 Jun 15.
|
| 49 |
Characterization of TEM1/endosialin in human and murine brain tumors.BMC Cancer. 2009 Nov 30;9:417. doi: 10.1186/1471-2407-9-417.
|
| 50 |
A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.Cell Rep. 2015 Jun 23;11(11):1809-21. doi: 10.1016/j.celrep.2015.05.027. Epub 2015 Jun 11.
|
| 51 |
Perfusion kinetics in human brain tumor with DCE-MRI derived model and CFD analysis.J Biomech. 2017 Jul 5;59:80-89. doi: 10.1016/j.jbiomech.2017.05.017. Epub 2017 May 25.
|
| 52 |
Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity.Front Oncol. 2019 Mar 13;9:135. doi: 10.3389/fonc.2019.00135. eCollection 2019.
|
| 53 |
Hypomethylation of CNTFR is associated with proliferation and poor prognosis in lower grade gliomas.Sci Rep. 2017 Aug 1;7(1):7079. doi: 10.1038/s41598-017-07124-9.
|
| 54 |
Development of dual casein kinase 1/1 (CK1/) inhibitors for treatment of breast cancer.Bioorg Med Chem. 2018 Feb 1;26(3):590-602. doi: 10.1016/j.bmc.2017.12.020. Epub 2017 Dec 15.
|
| 55 |
Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance.FEBS J. 2019 Aug;286(15):2870-2882. doi: 10.1111/febs.14967. Epub 2019 Jun 27.
|
| 56 |
CXCR4 and Glioblastoma.Anticancer Agents Med Chem. 2016;16(1):59-74. doi: 10.2174/1871520615666150824153032.
|
| 57 |
Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.J Cancer Res Clin Oncol. 2018 Jul;144(7):1227-1237. doi: 10.1007/s00432-018-2645-1. Epub 2018 Apr 25.
|
| 58 |
CYP2C9 polymorphisms in human tumors. Anticancer Res. 2006 Jan-Feb;26(1A):299-305.
|
| 59 |
Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors.Neurosci Lett. 2004 Jun 17;363(3):247-51. doi: 10.1016/j.neulet.2004.03.088.
|
| 60 |
Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.J Neurooncol. 2017 Jun;133(2):297-307. doi: 10.1007/s11060-017-2457-1. Epub 2017 May 29.
|
| 61 |
Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models.Neuroradiology. 2019 Dec;61(12):1375-1386. doi: 10.1007/s00234-019-02265-2. Epub 2019 Aug 7.
|
| 62 |
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.Genes Cancer. 2010 Aug;1(8):822-35. doi: 10.1177/1947601910383564.
|
| 63 |
EGFL7 enhances surface expression of integrin (5)(1) to promote angiogenesis in malignant brain tumors.EMBO Mol Med. 2018 Sep;10(9):e8420. doi: 10.15252/emmm.201708420.
|
| 64 |
GCN2 is essential for CD8(+) T cell survival and function in murine models of malignant glioma.Cancer Immunol Immunother. 2020 Jan;69(1):81-94. doi: 10.1007/s00262-019-02441-6. Epub 2019 Dec 16.
|
| 65 |
Targeting the erythropoietin receptor on glioma cells reduces tumour growth.Exp Cell Res. 2011 Oct 1;317(16):2321-32. doi: 10.1016/j.yexcr.2011.06.011. Epub 2011 Jun 30.
|
| 66 |
Novel target for peptide-based imaging and treatment of brain tumors.Mol Cancer Ther. 2014 Apr;13(4):996-1007. doi: 10.1158/1535-7163.MCT-13-0684. Epub 2014 Feb 3.
|
| 67 |
The isoprenoid derivative N(6) -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway.Br J Pharmacol. 2017 Jul;174(14):2287-2301. doi: 10.1111/bph.13824. Epub 2017 Jun 11.
|
| 68 |
Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors.Q J Nucl Med Mol Imaging. 2018 Jun;62(2):209-219. doi: 10.23736/S1824-4785.17.02807-2. Epub 2015 Sep 1.
|
| 69 |
FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation.Nat Commun. 2019 Jan 25;10(1):448. doi: 10.1038/s41467-018-08271-x.
|
| 70 |
Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with (89)Zr-Df-IAB2M anti-PSMA minibody.J Neurooncol. 2018 Jul;138(3):581-589. doi: 10.1007/s11060-018-2825-5. Epub 2018 Mar 9.
|
| 71 |
Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resection.Oncotarget. 2017 Jun 29;8(38):63715-63723. doi: 10.18632/oncotarget.18891. eCollection 2017 Sep 8.
|
| 72 |
t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.Blood. 2012 Nov 8;120(19):3949-57. doi: 10.1182/blood-2011-11-389908. Epub 2012 Sep 10.
|
| 73 |
Post-transcriptional regulation of glucose transporter-1 by an AU-rich element in the 3'UTR and by hnRNP A2.Biochem Biophys Res Commun. 2004 Jun 11;318(4):977-82. doi: 10.1016/j.bbrc.2004.04.128.
|
| 74 |
Cancer metabolism in a snapshot: MRS(I).NMR Biomed. 2019 Oct;32(10):e4054. doi: 10.1002/nbm.4054. Epub 2019 Jan 11.
|
| 75 |
IGFBP2 promotes glioma tumor stem cell expansion and survival.Biochem Biophys Res Commun. 2010 Jun 25;397(2):367-72. doi: 10.1016/j.bbrc.2010.05.145. Epub 2010 May 31.
|
| 76 |
cDNA clone, prokaryotic expression and purification of human interleukin-13 receptor [alpha]2 chain.Cancer Immunol Immunother. 2009 Mar;58(3):409-13. doi: 10.1007/s00262-008-0566-6. Epub 2008 Aug 2.
|
| 77 |
IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma.Nat Cell Biol. 2019 Aug;21(8):1003-1014. doi: 10.1038/s41556-019-0363-9. Epub 2019 Aug 1.
|
| 78 |
Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.Neuro Oncol. 2011 Dec;13(12):1308-23. doi: 10.1093/neuonc/nor134. Epub 2011 Sep 8.
|
| 79 |
Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1 interaction with cofactors p300/CBP.Clin Cancer Res. 2012 Dec 15;18(24):6623-33. doi: 10.1158/1078-0432.CCR-12-0861. Epub 2012 Aug 24.
|
| 80 |
KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?.BMC Cancer. 2009 Jun 22;9:196. doi: 10.1186/1471-2407-9-196.
|
| 81 |
GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease.J Cell Physiol. 2015 Jul;230(7):1661-76. doi: 10.1002/jcp.24919.
|
| 82 |
LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program.Oncotarget. 2013 Jul;4(7):1050-64. doi: 10.18632/oncotarget.1131.
|
| 83 |
LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti-PD-1 Therapy against Brain Tumors.Cancer Res. 2018 Dec 1;78(23):6607-6620. doi: 10.1158/0008-5472.CAN-18-0498. Epub 2018 Oct 9.
|
| 84 |
Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.J Neurosurg. 1995 May;82(5):858-63. doi: 10.3171/jns.1995.82.5.0858.
|
| 85 |
The c-Jun NH2-terminal kinase3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumors.J Hum Genet. 2001;46(4):182-7. doi: 10.1007/s100380170086.
|
| 86 |
Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway.Neuro Oncol. 2011 Jun;13(6):622-34. doi: 10.1093/neuonc/nor023. Epub 2011 May 9.
|
| 87 |
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma.Pathol Res Pract. 2020 Jan;216(1):152728. doi: 10.1016/j.prp.2019.152728. Epub 2019 Nov 11.
|
| 88 |
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.RNA Biol. 2018;15(11):1420-1432. doi: 10.1080/15476286.2018.1539607. Epub 2018 Nov 18.
|
| 89 |
Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.PLoS One. 2012;7(10):e47846. doi: 10.1371/journal.pone.0047846. Epub 2012 Oct 23.
|
| 90 |
Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).Hum Mol Genet. 2006 Apr 1;15(7):1059-70. doi: 10.1093/hmg/ddl021. Epub 2006 Feb 23.
|
| 91 |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.
|
| 92 |
Combined inhibition of vascular endothelial growth factor receptor signaling with temozolomide enhances cytotoxicity against human glioblastoma cells via downregulation of Neuropilin-1.J Neurooncol. 2016 May;128(1):29-34. doi: 10.1007/s11060-016-2091-3. Epub 2016 Mar 7.
|
| 93 |
Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma.Neuromolecular Med. 2014 Sep;16(3):529-39. doi: 10.1007/s12017-014-8303-0. Epub 2014 May 20.
|
| 94 |
Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.Nat Neurosci. 2016 Jun;19(6):798-806. doi: 10.1038/nn.4295. Epub 2016 Apr 25.
|
| 95 |
Roles of purinergic P2X(7) receptor in glioma and microglia in brain tumors.Cancer Lett. 2017 Aug 28;402:93-99. doi: 10.1016/j.canlet.2017.05.004. Epub 2017 May 20.
|
| 96 |
Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.Oncotarget. 2017 May 30;8(22):35877-35889. doi: 10.18632/oncotarget.16270.
|
| 97 |
Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic.Int J Nanomedicine. 2013;8:821-34. doi: 10.2147/IJN.S39072. Epub 2013 Feb 25.
|
| 98 |
Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.Int J Pharm. 2016 Aug 20;510(1):394-405. doi: 10.1016/j.ijpharm.2016.06.127. Epub 2016 Jun 29.
|
| 99 |
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.Nat Med. 2019 Mar;25(3):477-486. doi: 10.1038/s41591-018-0337-7. Epub 2019 Feb 11.
|
| 100 |
Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.Cancer Res. 2002 May 1;62(9):2468-73.
|
| 101 |
Expression of PDK-1 and DMBT1 in the thyroid carcinoma and its clinicopathological significance.Oncol Lett. 2019 Sep;18(3):2819-2824. doi: 10.3892/ol.2019.10639. Epub 2019 Jul 18.
|
| 102 |
Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.DNA Cell Biol. 2005 May;24(5):317-24. doi: 10.1089/dna.2005.24.317.
|
| 103 |
DNA polymerase deficiency in the p53 null cerebellum leads to medulloblastoma formation.Biochem Biophys Res Commun. 2018 Oct 28;505(2):548-553. doi: 10.1016/j.bbrc.2018.09.166. Epub 2018 Sep 29.
|
| 104 |
Prostate stem cell antigen is expressed in normal and malignant human brain tissues.Oncol Lett. 2018 Mar;15(3):3081-3084. doi: 10.3892/ol.2017.7632. Epub 2017 Dec 18.
|
| 105 |
Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.Oncogene. 2017 Jun 29;36(26):3673-3685. doi: 10.1038/onc.2016.493. Epub 2017 Mar 6.
|
| 106 |
The Tropism of Pleiotrophin: Orchestrating Glioma Brain Invasion.Cell. 2017 Aug 24;170(5):821-822. doi: 10.1016/j.cell.2017.08.011.
|
| 107 |
Novel somatic and germline mutations in intracranial germ cell tumours.Nature. 2014 Jul 10;511(7508):241-5. doi: 10.1038/nature13296. Epub 2014 Jun 4.
|
| 108 |
Expression of Rac3 in human brain tumors.J Clin Neurosci. 2005 Jun;12(5):571-4. doi: 10.1016/j.jocn.2004.08.013.
|
| 109 |
CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.Br J Cancer. 2017 Jun 27;117(1):102-112. doi: 10.1038/bjc.2017.157. Epub 2017 Jun 1.
|
| 110 |
The expression of rho proteins decreases with human brain tumor progression: potential tumor markers.Clin Exp Metastasis. 2002;19(1):9-15. doi: 10.1023/a:1013884426692.
|
| 111 |
The isoform A of reticulon-4 (Nogo-A) in cerebrospinal fluid of primary brain tumor patients: influencing factors.Oncotarget. 2018 May 18;9(38):25048-25056. doi: 10.18632/oncotarget.25278. eCollection 2018 May 18.
|
| 112 |
Nogo receptor-vimentin interaction: a novel mechanism for the invasive activity of glioblastoma multiforme.Exp Mol Med. 2019 Oct 24;51(10):1-15. doi: 10.1038/s12276-019-0332-1.
|
| 113 |
Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic value.Pathol Res Pract. 2019 Mar;215(3):427-432. doi: 10.1016/j.prp.2018.11.011. Epub 2018 Nov 12.
|
| 114 |
Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.Int J Clin Oncol. 2019 Dec;24(12):1515-1525. doi: 10.1007/s10147-019-01517-8. Epub 2019 Jul 27.
|
| 115 |
Expression and activation of signal regulatory protein alpha on astrocytomas.Cancer Res. 2004 Jan 1;64(1):117-27. doi: 10.1158/0008-5472.can-3455-2.
|
| 116 |
Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex.Epilepsia. 2011 Sep;52(9):1635-44. doi: 10.1111/j.1528-1167.2011.03111.x. Epub 2011 Jun 2.
|
| 117 |
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.Oncotarget. 2016 Nov 15;7(46):74630-74647. doi: 10.18632/oncotarget.11858.
|
| 118 |
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.Sci Rep. 2019 Feb 27;9(1):2878. doi: 10.1038/s41598-019-40013-x.
|
| 119 |
Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood-Brain Barrier in Glioblastoma Patients Using an IVIVE-PBPK Modeling Approach.Clin Cancer Res. 2017 Dec 15;23(24):7454-7466. doi: 10.1158/1078-0432.CCR-17-0983. Epub 2017 Sep 19.
|
| 120 |
SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance.Cell Prolif. 2016 Apr;49(2):195-206. doi: 10.1111/cpr.12241. Epub 2016 Feb 28.
|
| 121 |
Measuring sulfatase expression and invasion in glioblastoma.Methods Mol Biol. 2015;1229:507-16. doi: 10.1007/978-1-4939-1714-3_39.
|
| 122 |
HP1 is highly expressed in glioma cells and facilitates cell proliferation and survival.Cancer Biomark. 2017 Dec 6;20(4):453-460. doi: 10.3233/CBM-170249.
|
| 123 |
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events.J Neurol. 2019 Sep;266(9):2273-2276. doi: 10.1007/s00415-019-09410-0. Epub 2019 Jun 5.
|
| 124 |
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.Nature. 2011 Oct 5;478(7368):197-203. doi: 10.1038/nature10491.
|
| 125 |
Bioadhesive micelles of d--tocopherol polyethylene glycol succinate 1000: Synergism of chitosan and transferrin in targeted drug delivery.Colloids Surf B Biointerfaces. 2017 Apr 1;152:277-288. doi: 10.1016/j.colsurfb.2017.01.021. Epub 2017 Jan 15.
|
| 126 |
The transglutaminase 2 gene is aberrantly hypermethylated in glioma. J Neurooncol. 2011 Feb;101(3):429-40.
|
| 127 |
Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.Hum Gene Ther. 1995 Sep;6(9):1231-55. doi: 10.1089/hum.1995.6.9-1231.
|
| 128 |
Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.BMC Cancer. 2019 May 20;19(1):473. doi: 10.1186/s12885-019-5700-7.
|
| 129 |
Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.Cancer Res. 2019 May 15;79(10):2697-2708. doi: 10.1158/0008-5472.CAN-18-3125. Epub 2019 Mar 21.
|
| 130 |
microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.Neuro Oncol. 2018 Jan 22;20(2):215-224. doi: 10.1093/neuonc/nox138.
|
| 131 |
Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.Expert Rev Anticancer Ther. 2005 Apr;5(2):355-78. doi: 10.1586/14737140.5.2.355.
|
| 132 |
Expression of DNA topoisomerase I, IIalpha, and IIbeta in human brain tumors.Brain Tumor Pathol. 2000;17(1):7-13. doi: 10.1007/BF02478912.
|
| 133 |
TRIM28 as an independent prognostic marker plays critical roles in glioma progression.J Neurooncol. 2016 Jan;126(1):19-26. doi: 10.1007/s11060-015-1897-8.
|
| 134 |
Functional characterization of Trip10 in cancer cell growth and survival. J Biomed Sci. 2011 Feb 7;18:12.
|
| 135 |
TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative (18)F-GE-180 PET study.Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1368-1380. doi: 10.1007/s00259-019-04491-5. Epub 2019 Sep 5.
|
| 136 |
Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis.Dev Biol. 2007 May 15;305(2):599-614. doi: 10.1016/j.ydbio.2007.03.004. Epub 2007 Mar 12.
|
| 137 |
TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer.Cancer Manag Res. 2019 Jan 17;11:839-855. doi: 10.2147/CMAR.S186080. eCollection 2019.
|
| 138 |
Inhibiting Integrin 8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.Mol Cancer Res. 2019 Feb;17(2):384-397. doi: 10.1158/1541-7786.MCR-18-0386. Epub 2018 Sep 28.
|
| 139 |
Prognostic impact of CD68 and kallikrein 6 in human glioma.Anticancer Res. 2009 Aug;29(8):3269-79.
|
| 140 |
Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats.Chem Biol Interact. 2011 Jan 15;189(1-2):26-36. doi: 10.1016/j.cbi.2010.09.028. Epub 2010 Oct 7.
|
| 141 |
Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines.Oncogene. 2009 Sep 3;28(35):3121-31. doi: 10.1038/onc.2009.168. Epub 2009 Jun 22.
|
| 142 |
A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastoma.Cell Death Dis. 2018 Jul 10;9(7):767. doi: 10.1038/s41419-018-0799-z.
|
| 143 |
Hydrogen peroxide contributes to the manganese superoxide dismutase promotion of migration and invasion in glioma cells.Free Radic Res. 2011 Oct;45(10):1154-61. doi: 10.3109/10715762.2011.604321. Epub 2011 Aug 5.
|
| 144 |
Genetic Contribution of Polymorphisms in Glutathione S-Transferases to Brain Tumor Risk.Mol Neurobiol. 2016 Apr;53(3):1730-1740. doi: 10.1007/s12035-015-9097-2. Epub 2015 Mar 4.
|
| 145 |
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.Neuro Oncol. 2014 Jan;16(2):173-8. doi: 10.1093/neuonc/not229. Epub 2013 Dec 4.
|
| 146 |
NKCC1 Regulates Migration Ability of Glioblastoma Cells by Modulation of Actin Dynamics and Interacting with Cofilin.EBioMedicine. 2017 Jul;21:94-103. doi: 10.1016/j.ebiom.2017.06.020. Epub 2017 Jun 21.
|
| 147 |
Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain.Cells. 2019 Dec 4;8(12):1568. doi: 10.3390/cells8121568.
|
| 148 |
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. Int J Oncol. 2004 Aug;25(2):493-502.
|
| 149 |
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Mster protocols. Blood. 2009 Aug 13;114(7):1314-8.
|
| 150 |
Glutaminases in brain: Multiple isoforms for many purposes.Neurochem Int. 2015 Sep;88:1-5. doi: 10.1016/j.neuint.2015.03.006. Epub 2015 Mar 30.
|
| 151 |
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer.Br J Cancer. 2009 May 19;100(10):1687-96. doi: 10.1038/sj.bjc.6605042.
|
| 152 |
Spermidine/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness.Oncogene. 2019 Oct;38(41):6794-6800. doi: 10.1038/s41388-019-0917-0. Epub 2019 Aug 9.
|
| 153 |
Sulfotransferase 1A1 (SULT1A1) polymorphism and susceptibility to primary brain tumors.J Cancer Res Clin Oncol. 2008 Jan;134(1):109-14. doi: 10.1007/s00432-007-0256-3. Epub 2007 Jun 29.
|
| 154 |
Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.Cancer Gene Ther. 2006 Apr;13(4):385-92. doi: 10.1038/sj.cgt.7700898.
|
| 155 |
AXIN1 Expression and Localization in Meningiomas and Association to Changes of APC and E-cadherin.Anticancer Res. 2016 Sep;36(9):4583-94. doi: 10.21873/anticanres.11007.
|
| 156 |
The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.Int J Cancer. 2020 Jul 1;147(1):189-201. doi: 10.1002/ijc.32831. Epub 2020 Jan 7.
|
| 157 |
Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry.Acta Neuropathol Commun. 2018 Mar 2;6(1):21. doi: 10.1186/s40478-018-0523-3.
|
| 158 |
Krppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.BMC Cancer. 2018 Oct 22;18(1):1025. doi: 10.1186/s12885-018-4874-8.
|
| 159 |
Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.Hum Mol Genet. 2016 Sep 1;25(17):3849-3862. doi: 10.1093/hmg/ddw206. Epub 2016 Jul 11.
|
| 160 |
Microtubule actin cross-linking factor 1, a novel target in glioblastoma.Int J Oncol. 2017 Jan;50(1):310-316. doi: 10.3892/ijo.2016.3798. Epub 2016 Dec 9.
|
| 161 |
Glyco-genes change expression in cancer through aberrant methylation.Biochim Biophys Acta. 2016 Aug;1860(8):1776-85. doi: 10.1016/j.bbagen.2016.01.002. Epub 2016 Jan 12.
|
| 162 |
Expression of prostaglandin H synthase-2 in human brain tumors.Acta Neuropathol. 2001 Aug;102(2):181-7. doi: 10.1007/s004010100373.
|
| 163 |
Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome.Mol Cancer. 2005 Feb 3;4(1):9. doi: 10.1186/1476-4598-4-9.
|
| 164 |
PRG3 induces Ras-dependent oncogenic cooperation in gliomas.Oncotarget. 2016 May 3;7(18):26692-708. doi: 10.18632/oncotarget.8592.
|
| 165 |
Low density lipoprotein receptor related protein gene amplification and 766T polymorphism in astrocytomas.Neurosci Lett. 1998 Oct 30;256(1):5-8. doi: 10.1016/s0304-3940(98)00734-4.
|
| 166 |
Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.Neoplasia. 2012 Feb;14(2):84-94. doi: 10.1593/neo.111600.
|
| 167 |
Novel functional association of serine palmitoyltransferase subunit 1-A peptide in sphingolipid metabolism with cytochrome P4501A1 transactivation and proliferative capacity of the human Glioma LN18 brain tumor cell line.Int J Environ Res Public Health. 2006 Sep;3(3):252-61. doi: 10.3390/ijerph2006030030.
|
| 168 |
Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy.Mol Cancer. 2017 Jan 31;16(1):21. doi: 10.1186/s12943-017-0593-z.
|
| 169 |
Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours.Br J Cancer. 2006 Apr 24;94(8):1186-93. doi: 10.1038/sj.bjc.6603006.
|
| 170 |
Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.Neuropathol Appl Neurobiol. 2007 Feb;33(1):77-85. doi: 10.1111/j.1365-2990.2006.00786.x.
|
| 171 |
Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy cell index of high-grade glioblastoma.Mol Carcinog. 2016 Feb;55(2):148-60. doi: 10.1002/mc.22264. Epub 2015 Jan 15.
|
| 172 |
Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis.Cancer. 2007 Feb 15;109(4):761-6. doi: 10.1002/cncr.22475.
|
| 173 |
CABYR is a novel cancer-testis antigen in lung cancer.Clin Cancer Res. 2007 Feb 15;13(4):1288-97. doi: 10.1158/1078-0432.CCR-06-1742.
|
| 174 |
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2(+) Breast Cancer Metastasis to the Brain.Clin Cancer Res. 2018 Jan 1;24(1):95-105. doi: 10.1158/1078-0432.CCR-17-2041. Epub 2017 Oct 23.
|
| 175 |
Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.J Pharmacol Exp Ther. 2014 Jun;349(3):458-69. doi: 10.1124/jpet.114.214619. Epub 2014 Apr 2.
|
| 176 |
Brain DSC MR Perfusion in Children: A Clinical Feasibility Study Using Different Technical Standards of Contrast Administration.AJNR Am J Neuroradiol. 2019 Feb;40(2):359-365. doi: 10.3174/ajnr.A5954. Epub 2019 Jan 17.
|
| 177 |
Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.PLoS One. 2018 May 22;13(5):e0190001. doi: 10.1371/journal.pone.0190001. eCollection 2018.
|
| 178 |
Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model.Hum Gene Ther Methods. 2016 Jun;27(3):98-111. doi: 10.1089/hgtb.2015.168. Epub 2016 Apr 28.
|
| 179 |
HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death.Cells. 2019 Sep 20;8(10):1112. doi: 10.3390/cells8101112.
|
| 180 |
Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study.Anticancer Res. 2017 Oct;37(10):5777-5783. doi: 10.21873/anticanres.12019.
|
| 181 |
Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.Cell Commun Signal. 2017 Sep 18;15(1):34. doi: 10.1186/s12964-017-0189-7.
|
| 182 |
Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies.BMC Cancer. 2009 Aug 25;9:297. doi: 10.1186/1471-2407-9-297.
|
| 183 |
Crystal structure of the coiled-coil domain of Drosophila TRIM protein Brat.Proteins. 2019 Aug;87(8):706-710. doi: 10.1002/prot.25691. Epub 2019 Apr 19.
|
| 184 |
Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours.J Pathol. 2006 Aug;209(4):492-500. doi: 10.1002/path.1998.
|
| 185 |
Specific alternative HOX11 transcripts are expressed in paediatric neural tumours and T-cell acute lymphoblastic leukaemia.Gene. 2003 Dec 24;323:89-99. doi: 10.1016/j.gene.2003.09.001.
|
| 186 |
Effects of Radiation Exposure on the Cost-Effectiveness of CT Angiography and Perfusion Imaging in Aneurysmal Subarachnoid Hemorrhage.AJNR Am J Neuroradiol. 2017 Mar;38(3):462-468. doi: 10.3174/ajnr.A5034. Epub 2017 Jan 12.
|
| 187 |
Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma.Pharmacogenet Genomics. 2016 May;26(5):243-7. doi: 10.1097/FPC.0000000000000212.
|
| 188 |
ADAM 12: a putative marker of oligodendrogliomas?.Dis Markers. 2013;34(2):81-91. doi: 10.3233/DMA-120953.
|
| 189 |
Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.Int J Cancer. 2009 Mar 15;124(6):1258-62. doi: 10.1002/ijc.24023.
|
| 190 |
Altered adenosine-to-inosine RNA editing in human cancer.Genome Res. 2007 Nov;17(11):1586-95. doi: 10.1101/gr.6493107. Epub 2007 Oct 1.
|
| 191 |
Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma.FEBS Lett. 2004 Jul 2;569(1-3):307-16. doi: 10.1016/j.febslet.2004.06.011.
|
| 192 |
The biochemical, nanomechanical and chemometric signatures of brain cancer.Spectrochim Acta A Mol Biomol Spectrosc. 2018 Jan 5;188:8-19. doi: 10.1016/j.saa.2017.06.037. Epub 2017 Jun 30.
|
| 193 |
Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.J Clin Invest. 2019 Apr 8;129(5):1833-1835. doi: 10.1172/JCI128742. eCollection 2019 Apr 8.
|
| 194 |
Pediatric brain tumors: mutations of two dioxygenases (hABH2 and hABH3) that directly repair alkylation damage.J Neurooncol. 2009 Sep;94(2):195-201. doi: 10.1007/s11060-009-9837-0. Epub 2009 Mar 17.
|
| 195 |
Anosmin-1 contributes to brain tumor malignancy through integrin signal pathways.Endocr Relat Cancer. 2013 Dec 20;21(1):85-99. doi: 10.1530/ERC-13-0181. Print 2014 Feb.
|
| 196 |
Recognition of ADP-ribosylation factor 4-like by HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes from patients with brain tumors.Tissue Antigens. 2002 Oct;60(4):319-27. doi: 10.1034/j.1399-0039.2002.600406.x.
|
| 197 |
Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming.Cells. 2019 Jun 11;8(6):571. doi: 10.3390/cells8060571.
|
| 198 |
An Introduction to the Performance of Immunohistochemistry.Methods Mol Biol. 2019;1897:289-298. doi: 10.1007/978-1-4939-8935-5_25.
|
| 199 |
Multiparametric Analysis of Permeability and ADC Histogram Metrics for Classification of Pediatric Brain Tumors by Tumor Grade.AJNR Am J Neuroradiol. 2018 Mar;39(3):552-557. doi: 10.3174/ajnr.A5502. Epub 2018 Jan 4.
|
| 200 |
UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour.Br J Cancer. 2002 Oct 21;87(9):1006-12. doi: 10.1038/sj.bjc.6600593.
|
| 201 |
Molecular screening and genetic diversity analysis of anticancer Azurin-encoding and Azurin-like genes in human gut microbiome deduced through cultivation-dependent and cultivation-independent studies.Int Microbiol. 2019 Dec;22(4):437-449. doi: 10.1007/s10123-019-00070-8. Epub 2019 Mar 20.
|
| 202 |
Human BCAS3 expression in embryonic stem cells and vascular precursors suggests a role in human embryogenesis and tumor angiogenesis.PLoS One. 2007 Nov 21;2(11):e1202. doi: 10.1371/journal.pone.0001202.
|
| 203 |
Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.Oncogene. 2001 Jan 18;20(3):336-45. doi: 10.1038/sj.onc.1204098.
|
| 204 |
IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.Int J Mol Sci. 2019 Jun 21;20(12):3027. doi: 10.3390/ijms20123027.
|
| 205 |
Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53.Cancer Sci. 2017 Dec;108(12):2413-2421. doi: 10.1111/cas.13420. Epub 2017 Nov 6.
|
| 206 |
Risk factors and outcomes of severe acute respiratory failure requiring invasive mechanical ventilation in cancer patients: A retrospective cohort study.Med Intensiva (Engl Ed). 2018 Aug-Sep;42(6):354-362. doi: 10.1016/j.medin.2017.08.004. Epub 2017 Sep 28.
|
| 207 |
Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer.Prostate. 2001 Sep 15;48(4):292-6. doi: 10.1002/pros.1109.
|
| 208 |
Genetic variants of AICDA/CASP14 associated with childhood brain tumor.Genet Mol Res. 2013 Jun 20;12(2):2024-31. doi: 10.4238/2013.January.30.1.
|
| 209 |
Characterization of a novel anti-cancer compound for astrocytomas.PLoS One. 2014 Sep 25;9(9):e108166. doi: 10.1371/journal.pone.0108166. eCollection 2014.
|
| 210 |
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.Cancer Gene Ther. 2006 Sep;13(9):886-95. doi: 10.1038/sj.cgt.7700963. Epub 2006 Apr 28.
|
| 211 |
CD164 regulates proliferation, progression, and invasion of human glioblastoma cells.Oncotarget. 2019 Mar 12;10(21):2041-2054. doi: 10.18632/oncotarget.26724. eCollection 2019 Mar 12.
|
| 212 |
An evaluation of language in brain tumor patients using a new cognitively motivated testing protocol.Neuropsychology. 2017 Sep;31(6):648-665. doi: 10.1037/neu0000374. Epub 2017 Apr 6.
|
| 213 |
Arterial Spin-Labeling in Children with Brain Tumor: A Meta-Analysis.AJNR Am J Neuroradiol. 2018 Aug;39(8):1536-1542. doi: 10.3174/ajnr.A5727. Epub 2018 Aug 2.
|
| 214 |
CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating bloodbrain barrier permeability in tumor brain metastasis.Oncol Rep. 2018 Mar;39(3):1441-1453. doi: 10.3892/or.2018.6208. Epub 2018 Jan 10.
|
| 215 |
Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.Cancer Res. 2005 Jul 1;65(13):5523-34. doi: 10.1158/0008-5472.CAN-04-2582.
|
| 216 |
Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy.J Pathol. 2008 Mar;214(4):415-24. doi: 10.1002/path.2308.
|
| 217 |
HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer.Int J Mol Sci. 2018 Jul 24;19(8):2158. doi: 10.3390/ijms19082158.
|
| 218 |
Cathepsin B and its inhibitor stefin A in brain tumors.Pflugers Arch. 2000;439(3 Suppl):R122-3.
|
| 219 |
Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells.Acta Physiol (Oxf). 2011 Jul;202(3):563-81. doi: 10.1111/j.1748-1716.2010.02205.x. Epub 2010 Nov 12.
|
| 220 |
DAPK1 promoter hypermethylaiton in brain metastases and peripheral blood.Neoplasma. 2007;54(2):123-6.
|
| 221 |
Increased expression of diazepam binding inhibitor in human brain tumors.Cell Growth Differ. 1995 Mar;6(3):309-14.
|
| 222 |
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.Cancer Chemother Pharmacol. 2002 Dec;50(6):479-89. doi: 10.1007/s00280-002-0507-6. Epub 2002 Oct 17.
|
| 223 |
Doublecortin is preferentially expressed in invasive human brain tumors.Acta Neuropathol. 2005 Nov;110(5):472-80. doi: 10.1007/s00401-005-1070-0. Epub 2005 Sep 30.
|
| 224 |
Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females.Eur J Hum Genet. 2019 Aug;27(8):1254-1259. doi: 10.1038/s41431-019-0392-7. Epub 2019 Apr 1.
|
| 225 |
BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma.Neuropathol Appl Neurobiol. 2014 Apr;40(3):337-44. doi: 10.1111/nan.12072.
|
| 226 |
Expression of type II iodothyronine deiodinase in brain tumors.J Clin Endocrinol Metab. 2000 Nov;85(11):4403-6. doi: 10.1210/jcem.85.11.6952.
|
| 227 |
A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3).PLoS One. 2013 May 15;8(5):e64441. doi: 10.1371/journal.pone.0064441. Print 2013.
|
| 228 |
Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours.Int J Cancer. 2006 Jan 15;118(2):346-52. doi: 10.1002/ijc.21353.
|
| 229 |
COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors.Neuro Oncol. 2016 Oct;18(10):1425-33. doi: 10.1093/neuonc/now057. Epub 2016 Apr 18.
|
| 230 |
An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis.Cancer Res. 2006 Oct 1;66(19):9445-52. doi: 10.1158/0008-5472.CAN-06-1713.
|
| 231 |
Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis.Carcinogenesis. 2014 Apr;35(4):877-85. doi: 10.1093/carcin/bgt399. Epub 2013 Dec 4.
|
| 232 |
Expression of neu/c-erbB-2 in human brain tumors.Hum Pathol. 1994 Aug;25(8):772-80. doi: 10.1016/0046-8177(94)90246-1.
|
| 233 |
Eukaryotic initiation factor 5B (eIF5B) regulates temozolomide-mediated apoptosis in brain tumour stem cells (BTSCs).Biochem Cell Biol. 2020 Dec;98(6):647-652. doi: 10.1139/bcb-2019-0329. Epub 2019 Oct 31.
|
| 234 |
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.J Clin Oncol. 2008 Feb 20;26(6):919-24. doi: 10.1200/JCO.2007.14.1812.
|
| 235 |
Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22.Genomics. 1998 May 1;49(3):443-7. doi: 10.1006/geno.1998.5238.
|
| 236 |
NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors.Oncogene. 2009 Jan 22;28(3):378-89. doi: 10.1038/onc.2008.396. Epub 2008 Nov 3.
|
| 237 |
Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.Hum Mol Genet. 2000 Jun 12;9(10):1495-500. doi: 10.1093/hmg/9.10.1495.
|
| 238 |
Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.Genes Chromosomes Cancer. 2017 Oct;56(10):730-749. doi: 10.1002/gcc.22477. Epub 2017 Jul 1.
|
| 239 |
FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.Oncogene. 2008 Jul 10;27(30):4180-90. doi: 10.1038/onc.2008.61. Epub 2008 Mar 24.
|
| 240 |
Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif.Biochem Biophys Res Commun. 2004 Sep 10;322(1):197-202. doi: 10.1016/j.bbrc.2004.07.098.
|
| 241 |
Progress in Confocal Laser Endomicroscopy for Neurosurgery and Technical Nuances for Brain Tumor Imaging With Fluorescein.Front Oncol. 2019 Jul 3;9:554. doi: 10.3389/fonc.2019.00554. eCollection 2019.
|
| 242 |
Immunohistochemical detection of the gene product of Rous sarcoma virus in human brain tumors.Brain Res. 1985 Jul 1;337(2):201-7. doi: 10.1016/0006-8993(85)90055-1.
|
| 243 |
Mutation and deletion analysis of GFR alpha-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours.Br J Cancer. 1999 May;80(3-4):383-6. doi: 10.1038/sj.bjc.6690367.
|
| 244 |
Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.Int J Oncol. 2003 May;22(5):1045-9.
|
| 245 |
Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors.Mol Carcinog. 2010 Sep;49(9):818-25. doi: 10.1002/mc.20658.
|
| 246 |
Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe.Nanotechnology. 2019 Jul 5;30(27):275101. doi: 10.1088/1361-6528/ab0e9c. Epub 2019 Mar 11.
|
| 247 |
Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by the graded prognostic assessment: A meta-analysis (PRISMA) of randomized control trials.Medicine (Baltimore). 2018 Aug;97(33):e11777. doi: 10.1097/MD.0000000000011777.
|
| 248 |
DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas.Neuro Oncol. 2019 Jul 11;21(7):867-877. doi: 10.1093/neuonc/noz057.
|
| 249 |
Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.Acta Neuropathol Commun. 2017 Apr 17;5(1):28. doi: 10.1186/s40478-017-0436-6.
|
| 250 |
Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.PLoS One. 2009 Dec 31;4(12):e8536. doi: 10.1371/journal.pone.0008536.
|
| 251 |
Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces.Cancer Sci. 2009 Oct;100(10):1870-9. doi: 10.1111/j.1349-7006.2009.01269.x. Epub 2009 Jul 1.
|
| 252 |
Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling.Genes Dev. 2008 Aug 1;22(15):2028-33. doi: 10.1101/gad.1668708.
|
| 253 |
DMD and IL1RAPL1: two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors.Cytogenet Genome Res. 2007;119(3-4):196-203. doi: 10.1159/000112061. Epub 2008 Feb 1.
|
| 254 |
Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.Cancer Res. 2000 Mar 1;60(5):1168-72.
|
| 255 |
The novel conserved mitochondrial inner-membrane protein MTGM regulates mitochondrial morphology and cell proliferation.J Cell Sci. 2009 Jul 1;122(Pt 13):2252-62. doi: 10.1242/jcs.038513.
|
| 256 |
No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.Int J Cancer. 2004 Apr 10;109(3):476-9. doi: 10.1002/ijc.11715.
|
| 257 |
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.Nature. 2004 Mar 18;428(6980):328-32. doi: 10.1038/nature02329.
|
| 258 |
Inhibin alpha, beta A subunit and activin type II receptor mRNAs are expressed in human brain tumors.Endocr J. 1995 Jun;42(3):307-13. doi: 10.1507/endocrj.42.307.
|
| 259 |
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling.Brain. 2012 Apr;135(Pt 4):1055-69. doi: 10.1093/brain/aws028. Epub 2012 Mar 20.
|
| 260 |
Direct interaction of Gas41 and Myc encoded by amplified genes in nervous system tumours.Acta Biochim Pol. 2011;58(4):529-34. Epub 2011 Nov 8.
|
| 261 |
Oncogenic BRAF Alterations and Their Role in Brain Tumors.Cancers (Basel). 2019 Jun 8;11(6):794. doi: 10.3390/cancers11060794.
|
| 262 |
Embryonic Stem Cell-Related Protein L1TD1 Is Required for Cell Viability, Neurosphere Formation, and Chemoresistance in Medulloblastoma.Stem Cells Dev. 2015 Nov 15;24(22):2700-8. doi: 10.1089/scd.2015.0052. Epub 2015 Aug 10.
|
| 263 |
L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings.Neuropediatrics. 2008 Apr;39(2):119-22. doi: 10.1055/s-2008-1081217.
|
| 264 |
The histone code reader PHD finger protein 7 controls sex-linked disparities in gene expression and malignancy in Drosophila.Sci Adv. 2019 Aug 14;5(8):eaaw7965. doi: 10.1126/sciadv.aaw7965. eCollection 2019 Aug.
|
| 265 |
Changes in laminin isoforms associated with brain tumor invasion and angiogenesis.Front Biosci. 2006 Jan 1;11:81-8. doi: 10.2741/1781.
|
| 266 |
Expression of bisecting GlcNAc in pediatric brain tumors and its association with tumor cell response to vinblastine.Clin Cancer Res. 1999 Nov;5(11):3661-8.
|
| 267 |
Somatic alterations in brain tumors.Oncol Rep. 2008 Jul;20(1):203-10.
|
| 268 |
Lrig2-deficient mice are protected against PDGFB-induced glioma.PLoS One. 2013 Sep 4;8(9):e73635. doi: 10.1371/journal.pone.0073635. eCollection 2013.
|
| 269 |
Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamily.FEBS Lett. 2005 Jul 4;579(17):3674-82. doi: 10.1016/j.febslet.2005.05.058.
|
| 270 |
Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells.Cancer Gene Ther. 2011 Mar;18(3):206-18. doi: 10.1038/cgt.2010.71. Epub 2010 Nov 26.
|
| 271 |
JSAP1/JIP3 cooperates with focal adhesion kinase to regulate c-Jun N-terminal kinase and cell migration.J Biol Chem. 2005 Nov 11;280(45):37772-81. doi: 10.1074/jbc.M505241200. Epub 2005 Sep 2.
|
| 272 |
Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.Cancer Lett. 2015 Apr 1;359(1):87-96. doi: 10.1016/j.canlet.2014.12.049. Epub 2015 Jan 8.
|
| 273 |
Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.Cancer. 2004 Sep 1;101(5):1018-27. doi: 10.1002/cncr.20442.
|
| 274 |
alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas.Brain Res. 1997 Apr 25;755(1):175-9. doi: 10.1016/s0006-8993(97)00241-2.
|
| 275 |
Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.Clin Cancer Res. 2005 Jan 1;11(1):249-58.
|
| 276 |
Transcriptional expression of survivin and its splice variants in brain tumors in humans.J Neurosurg. 2003 Oct;99(4):738-45. doi: 10.3171/jns.2003.99.4.0738.
|
| 277 |
Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.Cancer Res. 1999 Jun 1;59(11):2570-6.
|
| 278 |
Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.Cancer Res. 2000 Feb 15;60(4):877-82.
|
| 279 |
Mutation analysis of the p73 gene in nonastrocytic brain tumours.Br J Cancer. 2001 Jul 20;85(2):204-8. doi: 10.1054/bjoc.2001.1855.
|
| 280 |
A novel infram deletion in MSH6 gene in glioma: Conversation on MSH6 mutations in brain tumors.J Cell Physiol. 2019 Jul;234(7):11092-11102. doi: 10.1002/jcp.27759. Epub 2018 Nov 27.
|
| 281 |
Metastasis tumor-associated protein-2 knockdown suppresses the proliferation and invasion of human glioma cells in vitro and in vivo.J Neurooncol. 2014 Nov;120(2):273-81. doi: 10.1007/s11060-014-1558-3. Epub 2014 Jul 22.
|
| 282 |
Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.Oncotarget. 2013 Nov;4(11):1904-18. doi: 10.18632/oncotarget.1264.
|
| 283 |
From cerebellar proliferation to tumorigenesis: new insights into the role of Mad3.Cell Cycle. 2008 Feb 15;7(4):423-7. doi: 10.4161/cc.7.4.5413. Epub 2007 Dec 6.
|
| 284 |
PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells.Nat Commun. 2014 Nov 21;5:5566. doi: 10.1038/ncomms6566.
|
| 285 |
Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).Anticancer Res. 2000 Jan-Feb;20(1A):305-10.
|
| 286 |
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.Sci Rep. 2018 Sep 17;8(1):13930. doi: 10.1038/s41598-018-32353-x.
|
| 287 |
A novel ninein-interaction protein, CGI-99, blocks ninein phosphorylation by GSK3beta and is highly expressed in brain tumors.FEBS Lett. 2004 May 21;566(1-3):162-8. doi: 10.1016/j.febslet.2004.04.024.
|
| 288 |
Cloning, expression and chromosomal location of NKX6B TO 10Q26, a region frequently deleted in brain tumors.Mamm Genome. 2001 Feb;12(2):157-62. doi: 10.1007/s003350010247.
|
| 289 |
Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.Nature. 2017 Sep 28;549(7673):533-537. doi: 10.1038/nature24014. Epub 2017 Sep 20.
|
| 290 |
Expression of N-myristoyltransferase in human brain tumors.Neurochem Res. 2005 Jan;30(1):9-13. doi: 10.1007/s11064-004-9680-9.
|
| 291 |
Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas.J Pathol. 2008 Oct;216(2):218-24. doi: 10.1002/path.2401.
|
| 292 |
NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.Cancer Lett. 2019 Jul 10;454:98-107. doi: 10.1016/j.canlet.2019.04.003. Epub 2019 Apr 10.
|
| 293 |
Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.J Neurooncol. 2004 May;67(3):265-71. doi: 10.1023/b:neon.0000024190.56750.81.
|
| 294 |
CEST MRI of 3-O-methyl-D-glucose uptake and accumulation in brain tumors.Magn Reson Med. 2019 Mar;81(3):1993-2000. doi: 10.1002/mrm.27489. Epub 2018 Sep 11.
|
| 295 |
Identification of transcriptional regulatory networks specific to pilocytic astrocytoma.BMC Med Genomics. 2011 Jul 11;4:57. doi: 10.1186/1755-8794-4-57.
|
| 296 |
Integration of PEG 400 into a self-nanoemulsifying drug delivery system improves drug loading capacity and nasal mucosa permeability and prolongs the survival of rats with malignant brain tumors.Int J Nanomedicine. 2019 May 16;14:3601-3613. doi: 10.2147/IJN.S193617. eCollection 2019.
|
| 297 |
PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas.Cancers (Basel). 2019 Oct 11;11(10):1537. doi: 10.3390/cancers11101537.
|
| 298 |
c-Myc regulates the coordinated transcription of brain disease-related PDCD10-SERPINI1 bidirectional gene pair.Mol Cell Neurosci. 2009 Sep;42(1):23-32. doi: 10.1016/j.mcn.2009.05.001. Epub 2009 May 13.
|
| 299 |
Venous Thromboembolism in Brain Tumors: Risk Factors, Molecular Mechanisms, and Clinical Challenges.Semin Thromb Hemost. 2019 Jun;45(4):334-341. doi: 10.1055/s-0039-1688493. Epub 2019 Apr 30.
|
| 300 |
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway.Oncogene. 2008 Feb 14;27(8):1155-66. doi: 10.1038/sj.onc.1210732. Epub 2007 Aug 13.
|
| 301 |
Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.Genes Dev. 2013 May 1;27(9):1032-45. doi: 10.1101/gad.212548.112.
|
| 302 |
Differential PIAS3 expression in human malignancy.Oncol Rep. 2004 Jun;11(6):1319-24.
|
| 303 |
PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFB.Sci Rep. 2017 Apr 11;7(1):835. doi: 10.1038/s41598-017-00947-6.
|
| 304 |
Bright Aggregation-Induced-Emission Dots for Targeted Synergetic NIR-II Fluorescence and NIR-I Photoacoustic Imaging of Orthotopic Brain Tumors.Adv Mater. 2018 May 28:e1800766. doi: 10.1002/adma.201800766. Online ahead of print.
|
| 305 |
Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression.Mol Cell Biol. 2011 Mar;31(6):1225-39. doi: 10.1128/MCB.00607-10. Epub 2011 Jan 18.
|
| 306 |
Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.Clin Cancer Res. 2005 Nov 1;11(21):7643-50. doi: 10.1158/1078-0432.CCR-05-1099.
|
| 307 |
Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome.Fam Cancer. 2019 Apr;18(2):261-265. doi: 10.1007/s10689-018-0112-4.
|
| 308 |
Genetic alterations of protein-o-mannosyltransferase-1 in glioneuronal and glial brain tumors with subarachnoid spread.Neuropathology. 2009 Apr;29(2):116-24. doi: 10.1111/j.1440-1789.2008.00954.x. Epub 2008 Jul 20.
|
| 309 |
Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway.FEBS Lett. 2013 Dec 11;587(24):3892-7. doi: 10.1016/j.febslet.2013.09.029. Epub 2013 Oct 11.
|
| 310 |
Rb family proteins in gastric cancer (review).Oncol Rep. 2010 Dec;24(6):1411-8. doi: 10.3892/or_00001000.
|
| 311 |
Prop-1 gene expression in human pituitary tumors.J Clin Endocrinol Metab. 1999 Jul;84(7):2581-4. doi: 10.1210/jcem.84.7.5974.
|
| 312 |
A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes.Brain Pathol. 1998 Jan;8(1):13-8. doi: 10.1111/j.1750-3639.1998.tb00129.x.
|
| 313 |
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9435-40. doi: 10.1073/pnas.0900571106. Epub 2009 May 28.
|
| 314 |
Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors.J Cell Commun Signal. 2019 Mar;13(1):75-84. doi: 10.1007/s12079-018-0476-0. Epub 2018 Jul 5.
|
| 315 |
Rab3a promotes brain tumor initiation and progression.Mol Biol Rep. 2014 Sep;41(9):5903-11. doi: 10.1007/s11033-014-3465-2. Epub 2014 Jun 26.
|
| 316 |
Rac2 expression and mutation in human brain tumors.Acta Neurochir (Wien). 2005 May;147(5):551-4; discussion 554. doi: 10.1007/s00701-005-0515-5. Epub 2005 Apr 4.
|
| 317 |
Implementation of a High-Throughput Pilot Screen in Peptide Hydrogel-Based Three-Dimensional Cell Cultures.SLAS Discov. 2019 Aug;24(7):714-723. doi: 10.1177/2472555219844570. Epub 2019 Apr 30.
|
| 318 |
Rare HRAS1 alleles are a risk factor for the development of brain tumors.Cancer. 2001 Dec 1;92(11):2920-6.
|
| 319 |
Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish model of RB1 embryonal brain tumor, and are required for neural progenitor survival and proliferation.Dis Model Mech. 2018 Jun 15;11(6):dmm034124. doi: 10.1242/dmm.034124.
|
| 320 |
Clinical significance of Polycomb gene expression in brain tumors.Mol Cancer. 2010 Sep 30;9:265. doi: 10.1186/1476-4598-9-265.
|
| 321 |
Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter.J Cell Biol. 1992 Dec;119(6):1681-7. doi: 10.1083/jcb.119.6.1681.
|
| 322 |
BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors.Nat Med. 2018 Nov;24(11):1662-1668. doi: 10.1038/s41591-018-0172-x. Epub 2018 Sep 17.
|
| 323 |
Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.J Cell Physiol. 2010 Sep;224(3):626-35. doi: 10.1002/jcp.22196.
|
| 324 |
Association of PD-1.5 C/T, but Not PD-1.3 G/A, with Malignant and Benign Brain Tumors in Iranian Patients.Immunol Invest. 2017 Jul;46(5):469-480. doi: 10.1080/08820139.2017.1296858. Epub 2017 May 23.
|
| 325 |
Inhibition of cell death by ribosomal protein L35a.Cancer Lett. 2002 Jun 28;180(2):195-202. doi: 10.1016/s0304-3835(02)00024-1.
|
| 326 |
Knockdown of ribosomal protein S15A induces human glioblastoma cell apoptosis.World J Surg Oncol. 2016 Apr 29;14:129. doi: 10.1186/s12957-016-0891-8.
|
| 327 |
Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines.Neuro Oncol. 2019 Mar 18;21(4):424-427. doi: 10.1093/neuonc/noz034.
|
| 328 |
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):370-375. doi: 10.1073/pnas.1616100114. Epub 2016 Dec 23.
|
| 329 |
SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.Oncotarget. 2015 May 20;6(14):12452-67. doi: 10.18632/oncotarget.3611.
|
| 330 |
Expression of Nedd5, a mammalian septin, in human brain tumors.J Neurooncol. 2002 May;57(3):169-77. doi: 10.1023/a:1015721801075.
|
| 331 |
Prognostic significance of Tks5 expression in gliomas.J Clin Neurosci. 2012 Mar;19(3):436-42. doi: 10.1016/j.jocn.2011.11.013. Epub 2012 Jan 16.
|
| 332 |
Single minded 2-s (SIM2-s) gene is expressed in human GBM cells and involved in GBM invasion.Cancer Biol Ther. 2010 Mar 15;9(6):430-6. doi: 10.4161/cbt.9.6.10892. Epub 2010 Mar 8.
|
| 333 |
Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines.Mol Cancer Ther. 2008 Jun;7(6):1461-71. doi: 10.1158/1535-7163.MCT-07-2010.
|
| 334 |
Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor.Cell Rep. 2019 Mar 5;26(10):2608-2621.e6. doi: 10.1016/j.celrep.2019.02.009.
|
| 335 |
The combination of 13N-ammonia and 18F-FDG PET/CT in the identification of metabolic phenotype of primary human brain tumors.Nuklearmedizin. 2019 Jun;58(3):272-278. doi: 10.1055/a-0835-5746. Epub 2019 Apr 17.
|
| 336 |
Investigation of cis-4-[(18)F]Fluoro-D-Proline Uptake in Human Brain Tumors After Multimodal Treatment.Mol Imaging Biol. 2018 Dec;20(6):1035-1043. doi: 10.1007/s11307-018-1197-8.
|
| 337 |
The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site.Mol Ther. 2014 Nov;22(11):1936-48. doi: 10.1038/mt.2014.134. Epub 2014 Jul 25.
|
| 338 |
SP100 reduces malignancy of human glioma cells.Int J Oncol. 2011 Apr;38(4):1023-30. doi: 10.3892/ijo.2011.927. Epub 2011 Jan 27.
|
| 339 |
Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells.Cells. 2019 Aug 1;8(8):808. doi: 10.3390/cells8080808.
|
| 340 |
Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.J Neurooncol. 2011 Sep;104(2):497-507. doi: 10.1007/s11060-010-0522-0. Epub 2011 Feb 24.
|
| 341 |
Medulloblastoma: a problem of developmental biology.Cancer Cell. 2002 Jul;2(1):7-8. doi: 10.1016/s1535-6108(02)00090-9.
|
| 342 |
Alternative polyadenylation in glioblastoma multiforme and changes in predicted RNA binding protein profiles.OMICS. 2013 Mar;17(3):136-49. doi: 10.1089/omi.2012.0098. Epub 2013 Feb 19.
|
| 343 |
Task-evoked reconfiguration of the fronto-parietal network is associated with cognitive performance in brain tumor patients.Brain Imaging Behav. 2020 Dec;14(6):2351-2366. doi: 10.1007/s11682-019-00189-2.
|
| 344 |
CD46 represents a target for adenoviral gene therapy of malignant glioma.Hum Gene Ther. 2006 May;17(5):556-64. doi: 10.1089/hum.2006.17.556.
|
| 345 |
Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis.BMC Genomics. 2011 Oct 14;12:505. doi: 10.1186/1471-2164-12-505.
|
| 346 |
Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor.Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26398. Epub 2016 Dec 14.
|
| 347 |
Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line.Molecules. 2018 May 9;23(5):1129. doi: 10.3390/molecules23051129.
|
| 348 |
Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line.Int J Cancer. 2005 Jul 20;115(6):998-1005. doi: 10.1002/ijc.20965.
|
| 349 |
TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-B activation and tumor progression.Oncogene. 2017 May 18;36(20):2813-2823. doi: 10.1038/onc.2016.430. Epub 2016 Dec 19.
|
| 350 |
TRK inhibitors in TRK fusion-positive cancers.Ann Oncol. 2019 Nov 1;30(Suppl_8):viii23-viii30. doi: 10.1093/annonc/mdz282.
|
| 351 |
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.Lancet Oncol. 2019 Oct;20(10):1444-1453. doi: 10.1016/S1470-2045(19)30502-9. Epub 2019 Sep 2.
|
| 352 |
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.Curr Neuropharmacol. 2018;16(5):618-626. doi: 10.2174/1570159X15666170630164226.
|
| 353 |
Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma.Cancer Res. 2014 Aug 15;74(16):4536-48. doi: 10.1158/0008-5472.CAN-13-3703. Epub 2014 Jun 19.
|
| 354 |
An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation.Cell Stem Cell. 2010 Jan 8;6(1):37-47. doi: 10.1016/j.stem.2009.11.002.
|
| 355 |
Downregulation of putative tumor suppressor gene TSC-22 in human brain tumors.J Surg Oncol. 2003 Jan;82(1):57-64. doi: 10.1002/jso.10180.
|
| 356 |
Expression of two testis-specific genes, TSGA10 and SYCP3, in different cancers regarding to their pathological features.Cancer Detect Prev. 2007;31(4):296-302. doi: 10.1016/j.cdp.2007.05.002.
|
| 357 |
Thyroid transcription factor-1 in primary CNS tumors.Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):437-43. doi: 10.1097/PAI.0b013e31820e6baf.
|
| 358 |
MUDENG Expression Profiling in Cohorts and Brain Tumor Biospecimens to Evaluate Its Role in Cancer.Front Genet. 2019 Sep 19;10:884. doi: 10.3389/fgene.2019.00884. eCollection 2019.
|
| 359 |
GLTSCR1, ATM, PPP1R13L and CD3EAP Genetic Variants and Lung Cancer Risk in a Chinese Population.Curr Med Sci. 2018 Aug;38(4):734-740. doi: 10.1007/s11596-018-1938-6. Epub 2018 Aug 20.
|
| 360 |
Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.Lab Invest. 2008 Sep;88(9):910-25. doi: 10.1038/labinvest.2008.66. Epub 2008 Jul 7.
|
| 361 |
Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.Cancer Res. 2010 Dec 1;70(23):9730-41. doi: 10.1158/0008-5472.CAN-10-1882. Epub 2010 Nov 23.
|
| 362 |
Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma.Fam Cancer. 2019 Apr;18(2):173-178. doi: 10.1007/s10689-018-0102-6.
|
| 363 |
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.Oncotarget. 2016 Nov 8;7(45):72431-72442. doi: 10.18632/oncotarget.11957.
|
|
|
|
|
|
|
